Fulgent Genetics (FLGT) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Fulgent Genetics (FLGT)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

18.99

+0.49 (2.65%)

as of Jun 10, 2026, 5:54:19 pm Market Open.

6 watching

SELL

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

We have some comments posted on FLGT. While it is not without potential, it is likely going to get worse before it bets better, growth-wise. The most recent quarterly earnings were fine as revenue continued to decline, but beat estimates, along with EPS. There are positives as the pharma side of the business is making progress with over 30 issued or active patents and a promising lead drug candidate. The balance sheet does continue to be strong. We are OK selling.
Unlock Premium - Try 5i Free

WATCH

They do genetic testing for rare diseases and other applications. They rolled out many tests during Covid, which became their major source of revenue (88%). Flush with that cash, they bought a company in August 2021, a good long-term opportunity in cancer testing. They didn't rest on their laurels. However, the market sees Fulgent as a Covid stock and has dumped it. Analysts expect their earnings to vanish in 2023. Do you believe in the rest of their business to have faith in it. He doesn't see much downside, but there's nothing urgent here to make him buy. He wants to see their Q4 numbers before making a movie. They have net cash of $900 million.

Showing 1 to 2 of 2 entries

Fulgent Genetics (FLGT) Frequently Asked Questions

What is Fulgent Genetics stock symbol?

Fulgent Genetics is a American stock, trading under the symbol FLGT (previously FLGT-Q on Stockchase) on the NASDAQ (FLGT). It is usually referred to as NASDAQ:FLGT or FLGT

Is Fulgent Genetics a buy or a sell?

In the last year, there was no coverage of Fulgent Genetics published on Stockchase.

Is Fulgent Genetics a good investment or a top pick?

Fulgent Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Fulgent Genetics.

Why is Fulgent Genetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Fulgent Genetics worth watching?

0 stock analysts on Stockchase covered Fulgent Genetics in the last year. It is a trending stock that is worth watching.

What is Fulgent Genetics stock price?

On 2026-06-10, Fulgent Genetics (FLGT) stock closed at a price of $18.99.

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Fulgent Genetics (FLGT)